跳至主要内容
临床试验/NCT05564832
NCT05564832招募中早期 1 期

Pharmacological Treatment of Presbyopia by Pilocarpine 1.25% Eye Drops

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2022年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
招募中
入组人数
75
试验地点
1
主要终点
The changes of near vision after one hour following pilocarpine eye drop

研究概览

简要总结

In this clinical trial, a total of 75 presbyopic patients in the age range of 40 to 60 years old will be participated. The right eyes of 45 patients will be treated by Biocarpine® and they will be considered as the case group, their left eyes will be defined as the controls. In another case group, the right eyes of 30 patients will received Vuity® eye drops and their left eyes will be considered as controls.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with the best corrected visual acuity (BCVA) better than 0.3LogMAR
  • Patients with the symptom of blurred vision at near distance

排除标准

  • Patients with amblyopia, cataract, corneal opacity, glaucoma, intraocular surgery, eye troma, congenital pupil anomalies and those with the history of headache and allergy to the eye drop will be excluded from the study.

研究组 & 干预措施

Pilocarpine Therapy

Experimental

The right eyes of 45 patients will be treated by Biocarpine® and Vuity® eye drops. They will be considered as the case group,

干预措施: Pilocarpine 1.25% Eye drop (Drug)

结局指标

主要结局

The changes of near vision after one hour following pilocarpine eye drop

时间窗: baseline to one hour after pilocarpine insillation

The near vision will be measured based on the LogMAR vision at a distance of 33cm before and one hour after instillation of 1.25% pilocarpine eye drop.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hamideh Sabbaghi

Assistant Professor

Shahid Beheshti University of Medical Sciences

研究点 (1)

Loading locations...

相似试验